×

Randomized trial of botulinum toxin to prevent pes cavus progression in pediatric charcot-marie-tooth disease type 1A: Burns J et al.

Musscle Nerve  42: 262–267, 2010
Authors
JOSHUA BURNS, PhD, 1,2
ADAM SCHEINBERG, MMed, 3,4
MONIQUE M. RYAN, MMed, 5
KRISTY J. ROSE, MHSc, 2
and ROBERT A. OUVRIER, MD, 2
Author Details
Faculty of Health Sciences, University of Sydney, Sydney, New South Wales, Australia 
Institute for Neuroscience and Muscle Research, Children’s Hospital at Westmead, Locked Bag 4001, Sydney,New South Wales 2145, Australia 
Department of Rehabilitation, The Children’s Hospital at Westmead, Sydney, New South Wales, Australia 
 Victorian Paediatric Rehabilitation Service, Victoria, Australia 
Children’s Neuroscience Centre, Royal Children’s Hospital/Murdoch Children’s Research Institute/Department of Paediatrics,Faculty of Medicine, University of Melbourne, Victoria, Australia

Please click here!

Botulinum toxin type A in the treatment of lower-limb spasticity in children with cerebral palsy: Camargo CHF et al.

Arq Neuropsiquiatr 2009;67(1):62-68
Authors
Carlos Henrique F. Camargo
Hélio A.G. Teive
Marise Zonta
Gilmar C. Silva
Marcelo R. Oliveira
Maurício M. Roriz
Ivar V. Brandi
Nilson Becker 
Rosana Hermínia Scola
Lineu César Werneck 

Please click here!

The management of spastic equinus in cerebral palsy: Cobeljic G et al.

2009, Orthopaedics and Trauma 23:3
Authors
Goran Cobeljic
Marko Bumbasirevic
Aleksandar Lesic
Zoran Bajin

Please click here!

A systematic review on the diagnosis and treatment of primary (idiopathic) dystonia and dystonia plus syndromes: report of an EFNS/MDS-ES Task Force: Albanese A M et al.

European Journal of Neurology  2006,  13: 433–444
doi:10.1111/j.1468-1331.2006.01537.x
Authors
Membership: A. Albanese (chairman) a,
M. P. Barnes  b, 
K. P. Bhatia  c,
E. Fernandez-Alvarez  d,
G. Filippini  a,
T. Gasser   e,
J. K. Krauss  f,
A. Newton  g,
I. Rektor  h,
M. Savoiardo  a,
J. Valls-Solei
Author Details
a  Istituto Nazionale Neurologico Carlo Besta, Milan, Italy;
b Hunters Moor Regional Rehabilitation Centre, Newcastle Upon Tyne, UK;
c  Institute of Neurology, University College London, Queen Square, London, UK;
d Neuropediatric Department, Hospital San Joan de Dieu, Barcelona, Spain;
e Department of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research, University of Tuebingen, Germany;
Department of Neurosurgery, Medical University of Hanover, MHH, Hannover, Germany;
European Dystonia Federation,Brussels, Belgium;
First Department of Neurology, Masaryk University, St. Anne’s Teaching Hospital, Brno, Czech Republic; and 
i  Neurology Department, Hospital Clı´ nic, Barcelona, Spain

Please click here!

Split-Screen Video Demonstration of Sonography-Guided Muscle Identification and Injection of Botulinum Toxin: Fietzek U M et al.

Movement Disorders
Vol. 25, No. 13, 2010, pp. 2225–2252
2010 Movement Disorder Society
Authors
Urban M. Fietzek, MD, 1
A. Sebastian Schroeder, MD, 2
Joerg Wissel, MD, PhD, 3
Florian Heinen, MD, PhD, 2
and Steffen Berweck, MD, PhD 2,4 *
Author Details:
1   Neurologisches Krankenhaus Muuenchen, Center for  Parkinson’s Disease and Movement Disorders, Muuenchen, Germany;
Department of Pediatric Neurology and Developmental Medicine, Dr. von Hauners’ Children’s Hospital, Ludwig-Maximilians-University Munich, Muuenchen, Germany;
3  Neurologische Rehabilitationsklinik, Beelitz-Heilstaaetten, Beelitz-Heilstaaetten, Germany;
4  Treatment Centre Vogtareuth, Specialist Centre for  Neuropediatric Rehabilitation, Vogtareuth, Germany

Please click here!

International Neurology – A Clinical Approach: (Editors) Lisak RP et al.

2009, A Clinical Approach
This edition first published 2009, ©2009 by Blackwell Publishing Ltd

EDITED BY
ROBERT P. LISAK MD FAAN FRCP
Parker Webber Chair in NeurologyProfessor and Chair of NeurologyProfessor of Immunology and MicrobiologyWayne State University School of Medicine;Neurologist-in-Chief, Detroit Medical CenterChief of Neurology, Harper University HospitalDetroit, MI, USA
DANIEL D. TRUONG MD FAAN
Head of The Parkinson and Movement Disorder InstituteMemorial Neuroscience InstituteOrange Coast Memorial Medical CenterFountain Valley, CA, USA
WILLIAM M. CARROLL MBBS MD FRACP FRCP(E)
Head of Neurology and Clinical NeurophysiologySir Charles Gairdner HospitalNedlands, Perth, Australia
ROONGROJ BHIDAYASIRI  MD FRCP
DirectorChulalongkorn Comprehensive Movement Disorders CenterChulalongkorn University HospitalBangkok, Thailand;University of California at Los AngelesLos Angeles, CA, USA
FOREWORD BY JOHN WALTON (LORD WALTON OF DETCHANT

Please click here!

Treatments for spasticity and pain in multiple sclerosis: a systematic review: Beard S et al.

Health Technol Assess 2003; 7 (40).
Authors
S Beard A Hunn J Wight
School of Health and Related Research (ScHARR),University of Sheffield, UK

Please click here!

Botulinum Toxin Type a for Upper Limb Spasticity Following Stroke: An Open-Label Study With Individualised, Flexible Injection Regimens: Slawek J et al.

Neurol Sci (2005) 26:32–39
DOI 10.1007/s10072-005-0379-8
Authors
J. Slawek, A. Bogucki, D. Reclawowicz

Please click here!

Best Clinical Practice in Botulinum Toxin Treatment for Children with Cerebral Palsy: Strobl W et al.

Toxins 2015, 1629-1648; doi:10.3390/toxins7051629
ISSN 2072-6651
www.mdpi.com/journal/toxins
Authors
Walter Strobl  1,†,
Tim Theologis  2,
Reinald Brunner  3,
Serdar Kocer  4,
Elke Viehweger  5,
Ignacio Pascual-Pascual  6 and
Richard Placzek  7,†,*
Author Details
1    Department of Paediatric- and Neuro-Orthopaedics, Orthopaedic Hospital Rummelsberg,90592 Schwarzenbruck, Germany and MOTIO, 1080 Vienna, Austria;E-Mail: walter.strobl@sana.de
2   Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, Nuffield Orthopaedic Centre, Windmill Road Headington, Oxford OX3 7LD, Oxfordshire, UK;E-Mail: timtheologis@googlemail.com
3   Department of Paediatric- and Neuro-Orthopaedics, University Children’s Hospital Basel (UKBB),Spitalstrasse 33, 4056 Basel, Switzerland; E-Mail: reinald.brunner@ukbb.ch
4   Centre de Réadaptation de COUBERT (Ugecam) 77170, France and ROMATEM,Etiler Istanbul 34337, Turkey; E-Mail: skocer1@gmail.com
5   Pediatric Orthopaedics and Institue of Motion Sciences Department, Aix-Marseille Université,Boulevard Jean Moulin, Marseille 13885, France; E-Mail: elke.viehweger@mail.ap-hm.fr
6   Department of Paediatrics, Hospital Infantil La Paz, Universidad Autonóma de Madrid, Madrid,Spain; E-Mail: sipascual@telefonica.net
7   Orthopedic Department, University Hospital Bonn, Sigmund-Freud-Str. 25, 53127 Bonn, Germany
These authors contributed equally to this work.
* Author to whom correspondence should be addressed; E-Mail: richard.placzek@ukb.uni-bonn.de;Tel.: +49-0228-287-14170; Fax: +49-0228-287-14175.Academic Editor: Bahman Jabbari

Please click here!

Intrathecal Baclofen for Spastic Hypertonia From Stroke Editorial Comment: Meythaler JM et al.

Stroke . 2001;32:2099-2109
Authors
Jay M. Meythaler, JD, MD; Sharon Guin-Renfroe, RN, MSN, CRNP;Robert C. Brunner, MD; Mark N. Hadley, MD

 

Please click here!

Management of Spasticity Associated Pain with Botulinum Toxin A: Wissel J et al.

2000, Journal of Pain and Symptom Management, Vol. 20 No. 1 July 2000

Author Details
Jörg Wissel, MD, Jörg Müller, MD, Jürgen Dressnandt, MD, Florian Heinen, MD, Markus Naumann, MD, Helge Topka, MD, and Werner Poewe, MD
Department of Neurology (J.W., J.M., W.P.), University of Innsbruck, Innsbruck, Austria; Hospital forNeurology (J.D.), Bad Aibling; Department of Neuropediatrics (F.H.), University of Freiburg, Freiburg; Department of Neurology (M.N.), University of Würzburg, Würzburg; and Department of Neurology(H.T.), University of Tübingen, Tübingen, Germany 

Please click here!

Abstracts of Scientific Papers and Posters Presented at the Annual Meeting of the Association of Academic Physiatrists Medical Student Category Award Winner TUNING ALGORITHMS FOR CONTROL INTERFACES FOR USERS WITH UPPER LIMB IMPAIRMENTS: Zhou L

Bonita Springs, Florida  April 6–10, 2010

 

Please click here!